NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 48 filers reported holding NUVALENT INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,877,507 | +43.6% | 40,842 | +31.8% | 0.00% | 0.0% |
| Q2 2023 | $1,307,017 | -9.9% | 30,994 | -44.3% | 0.00% | 0.0% |
| Q1 2023 | $1,451,413 | +121.0% | 55,631 | +152.3% | 0.00% | 0.0% |
| Q4 2022 | $656,738 | +4278.3% | 22,053 | +2723.7% | 0.00% | – |
| Q3 2022 | $15,000 | -42.3% | 781 | -59.0% | 0.00% | – |
| Q2 2022 | $26,000 | +13.0% | 1,904 | +16.0% | 0.00% | – |
| Q1 2022 | $23,000 | -70.1% | 1,642 | -59.4% | 0.00% | – |
| Q4 2021 | $77,000 | +175.0% | 4,046 | +225.2% | 0.00% | – |
| Q3 2021 | $28,000 | – | 1,244 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,341,024 | $436,140,000 | 8.51% |
| Fairmount Funds Management LLC | 914,614 | $20,625,000 | 7.50% |
| Bain Capital Life Sciences Investors, LLC | 3,428,014 | $77,302,000 | 4.80% |
| VR Adviser, LLC | 803,951 | $18,129,000 | 2.33% |
| Boxer Capital, LLC | 1,210,192 | $27,290,000 | 0.95% |
| BVF INC/IL | 448,512 | $10,114,000 | 0.40% |
| Avoro Capital Advisors LLC | 1,257,671 | $22,288,000 | 0.35% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,052,394 | $23,731,000 | 0.28% |
| Perceptive Advisors | 750,000 | $16,913,000 | 0.25% |
| Logos Global Management LP | 134,650 | $2,733,000 | 0.20% |